Theravance Biopharma Inc (TBPH)
Capital Expenditure
-$8.00K
TTM · Period ending: · USD
TBPH Capital Expenditure
Latest reported-$8.00Kperiod ending
Latest reported-$8.00Kperiod ending
TBPH TTM CapEx (-$2.73M → -$8.00K)
TTM CapEx
High-resolution chart · PNG
TBPH capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -8,000 | |
| -42,000 | |
| -42,000 | |
| -224,000 | |
| -239,000 | |
| -241,000 | |
| -332,000 | |
| -819,000 | |
| -825,000 | |
| -1,641,000 | |
| -2,488,000 | |
| -2,077,000 | |
| -1,999,000 | |
| -1,260,000 | |
| -572,000 | |
| -750,000 | |
| -1,846,000 | |
| -1,889,000 | |
| -3,406,000 | |
| -4,206,000 | |
| -5,217,000 | |
| -7,429,000 | |
| -6,616,000 | |
| -6,675,000 | |
| -4,702,000 | |
| -2,910,000 | |
| -3,176,000 | |
| -3,373,000 | |
| -5,171,000 | |
| -5,689,000 | |
| -7,240,000 | |
| -5,995,000 | |
| -4,946,000 | |
| -4,590,000 | |
| -2,406,000 | |
| -2,551,000 | |
| -2,138,000 | |
| -2,038,000 | |
| -2,135,000 | |
| -2,341,000 | |
| -2,602,000 | |
| -2,674,000 | |
| -2,647,000 | |
| -2,806,000 | |
| -2,593,000 | |
| -2,144,000 | |
| -3,107,000 | |
| -3,408,000 | |
| -3,184,000 | |
| -3,614,000 | |
| -2,734,000 | |
| -1,929,000 | |
| -2,259,000 |